The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Mitochondrial Oxidative Stress Mediates Angiotensin II–Induced Cardiac Hypertrophy and Gαq Overexpression–Induced Heart Failure
Open accessAbstract
Rationale: Mitochondrial dysfunction has been implicated in several cardiovascular diseases; however, the roles of mitochondrial oxidative stress and DNA damage in hypertensive cardiomyopathy are not well understood. Objective: We evaluated the contribution of mitochondrial reactive oxygen species (ROS) to cardiac hypertrophy and failure by using genetic mouse models overexpressing catalase targeted to mitochondria and to peroxisomes. Methods and Results: Angiotensin II increases mitochondrial ROS in cardiomyocytes, concomitant with increased mitochondrial protein carbonyls, mitochondrial DNA deletions, increased autophagy and signaling for mitochondrial biogenesis in hearts of angiotensin II–treated mice. The causal role of mitochondrial ROS in angiotensin II–induced cardiomyopathy is shown by the observation that mice that overexpress catalase targeted to mitochondria, but not mice that overexpress wild-type peroxisomal catalase, are resistant to cardiac hypertrophy, fibrosis and mitochondrial damage induced by angiotensin II, as well as heart failure induced by overexpression of Gαq. Furthermore, primary damage to mitochondrial DNA, induced by zidovudine administration or homozygous mutation of mitochondrial polymerase γ, is also shown to contribute directly to the development of cardiac hypertrophy, fibrosis and failure. Conclusions: These data indicate the critical role of mitochondrial ROS in cardiac hypertrophy and failure and support the potential use of mitochondrial-targeted antioxidants for prevention and treatment of hypertensive cardiomyopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various signs of increased oxidative stress have been reported in various cardiovascular-related diagnoses such as heart failure (Dai et al. 2012), ventricular hypertrophy (Dai et al. 2011), myocardial infarction (Merabet et al. 2012), diabetes (Anderson et al. 2009) and other conditions.”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Dai et al. 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods in Mammalian Autophagy Research
Mizushima, N., Yoshimori, T., & Levine, B. (2010) · Cell · doi:10.1016/j.cell.2010.01.028 · Cited by 4,497
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233
Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging
Kujoth, G. C., Hiona, A., Pugh, T. D., Someya, S., Panzer, K., Wohlgemuth, S. E., Hofer, T., Seo, A. Y., Sullivan, R., Jobling, W. A., et al. (2005) · Science · doi:10.1126/science.1112125 · Cited by 2,165
Self-citationExtension of murine life span by overexpression of catalase targeted to mitochondria
Schriner, S. E., Linford, N. J., Martin, G. M., Treuting, P., Ogburn, C. E., Emond, M., Coskun, P. E., Ladiges, W., Wolf, N., Van Remmen, H., et al. (2005) · Science · doi:10.1126/science.1106653 · Cited by 1,724
Self-citationMolecular Mechanisms of Human Hypertension
Lifton, R. P., Gharavi, A. G., & Geller, D. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00241-0 · Cited by 1,686
Mitochondrial Respiratory-Chain Diseases
DiMauro, S., & Schon, E. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022567 · Cited by 1,672
Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253
Self-citationTranscriptional control of mitochondrial biogenesis: the central role of PGC-1
Ventura-Clapier, R., Garnier, A., & Veksler, V. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn098 · Cited by 932
Cited by
Sorted by citations
Items 101–200 of 526
Ucer, S., Iyer, S. V., Kim, H., Han, L., Rutlen, C., Allison, K. C., Thostenson, J. D., de Cabo, R., Jilka, R. L., O’Brien, C. A., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3014 · Cited by 123
The renin–angiotensin system and its involvement in vascular disease
van Thiel, B. S., van der Pluijm, I., Riet, L. T., Essers, J., & Danser, A. H. J. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.090 · Cited by 120
Mitochondria Oxidative Stress, Connexin43 Remodeling, and Sudden Arrhythmic Death
Sovari, A. A., Rutledge, C. A., Jeong, E.-M., Dolmatova, E. V., Arasu, D., Liu, H., Vahdani, N., Gu, L., Zandieh, S., Xiao, L., et al. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.112.976787 · Cited by 114
Compartment-specific Control of Reactive Oxygen Species Scavenging by Antioxidant Pathway Enzymes
Dey, S., Sidor, A., & O'Rourke, B. P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.726968 · Cited by 115
Angiotensin II and Oxidative Stress in the Failing Heart
Zablocki, D., & Sadoshima, J. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4588 · Cited by 110
Oxidative stress-mediated effects of angiotensin II in the cardiovascular system
Wen, H. (2012) · World Journal of Hypertension · doi:10.5494/wjh.v2.i4.34 · Cited by 109
Role of oxidants on calcium and sodium movement in healthy and diseased cardiac myocytes
Sag, C. M., Wagner, S., & Maier, L. S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.035 · Cited by 112
Lai, L., Yan, L., Gao, S., Hu, C., Ge, H., Davidow, A. L., Park, M., Bravo, C., Iwatsubo, K., Ishikawa, Y., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.001212 · Cited by 106
Lozhkin, A. P., Vendrov, A. E., Ramos‐Mondragón, R., Canugovi, C., Stevenson, M., Herron, T. J., Hummel, S. L., Figueroa, C. A., Bowles, D. E., Isom, L. L., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102474 · Cited by 105
Li, Y., Zhang, C., Wu, Y.-N., Han, Y.-L., Cui, W., Jia, L., Cai, L., Cheng, J.-Z., Li, H.-H., & Du, J. (2012) · Arteriosclerosis, Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.249706 · Cited by 92
ROS signalling between endothelial cells and cardiac cells
Zhang, M., & Shah, A. M. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu050 · Cited by 105
Gαq signalling: The new and the old
Sánchez-Fernández, G., Cabezudo, S., García‐Hoz, C., Benincá, C., Aragay, A. M., Mayor, F., & Ribas, C. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.01.010 · Cited by 104
Mitochondrial energetics and calcium coupling in the heart
Kohlhaas, M., Nickel, A. G., & Maack, C. (2017) · The Journal of Physiology · doi:10.1113/jp273609 · Cited by 102
Mitochondrial Maturation in Human Pluripotent Stem Cell Derived Cardiomyocytes
Dai, D., Danoviz, M. E., Wiczer, B. M., Laflamme, M. A., & Tian, R. (2017) · Stem Cells International · doi:10.1155/2017/5153625 · Cited by 103
Self-citationHeart Failure and Mitochondrial Dysfunction
Knowlton, A. A., Chen, L., & Malik, Z. A. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000432861.55968.a6 · Cited by 100
Mitochondrial calcium in cardiac ischemia/reperfusion injury and cardioprotection
Bertero, E., Popoiu, T.-A., & Maack, C. (2024) · Basic Research in Cardiology · doi:10.1007/s00395-024-01060-2 · Cited by 111
Protein Quality Control and Metabolism: Bidirectional Control in the Heart
Wang, Z. V., & Hill, J. A. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.016 · Cited by 95
Kim, S.-J., Cheresh, P., Jablonski, R. P., Morales‐Nebreda, L., Cheng, Y., Hogan, E., Yeldandi, A. V., Chi, M., Aillon, R. P., Ridge, K. M., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.007 · Cited by 92
Andreadou, I., Schulz, R., Papapetropoulos, A., Turan, B., Ytrehus, K., Ferdinandy, P., Daiber, A., & Lisa, F. D. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15279 · Cited by 92
Pathogenesis of Chronic Cardiorenal Syndrome: Is There a Role for Oxidative Stress?
Rubattu, S., Mennuni, S., Testa, M., Mennuni, M., Pierelli, G., Pagliaro, B., Gabriele, E., Coluccia, R., Autore, C., & Volpe, M. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141123011 · Cited by 89
PINK1/Parkin-mediated mitophagy in cardiovascular disease: From pathogenesis to novel therapy
Wu, Y., Jiang, T., Hua, J., Xiong, Z., Dai, K., Chen, H., Li, L., Peng, J., Peng, X., Zheng, Z., et al. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.05.025 · Cited by 91
Jin, L.-W., Horiuchi, M., Wulff, H., Liu, X.-B., Cortopassi, G. A., Erickson, J. D., & Maezawa, I. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2778-14.2015 · Cited by 88
“…in inner mitochondrial membrane and help scavenge hydroxyl radicals and peroxynitrite and possibly HOCl and peroxyl radicals (Gruber et al., 2013); and (2) mCAT, a plasmid that has been shown to direct the expression of catalase only in the mitochondria (Schriner et al., 2005; Dai et al., 2011).”
BackgroundMethodMeulmeester, F. L., Luo, J. M., Martens, L. G., Mills, K. A., van Heemst, D., & Noordam, R. (2022) · Antioxidants · doi:10.3390/antiox11122322 · Cited by 103
IDH2 deficiency promotes mitochondrial dysfunction and cardiac hypertrophy in mice
Ku, H. J., Ahn, Y., Lee, J. H., Park, K. M., & Park, J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.12.018 · Cited by 86
Mitochondrial protection by simvastatin against angiotensin II‐mediated heart failure
Hsieh, C., Li, C., Hsu, C., Chen, H., Chen, Y., Liu, Y., Liu, Y., Kuo, H., & Liu, P. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14781 · Cited by 82
Retrograde mitochondrial signaling governs the identity and maturity of metabolic tissues
Walker, E. M., Pearson, G. L., Lawlor, N. T., Stendahl, A. M., Lietzke, A. C., Sidarala, V., Zhu, J., Stromer, T., Reck, E. C., Li, J., et al. (2025) · Science · doi:10.1126/science.adf2034 · Cited by 94
Chen, F., Chen, B., Xiao, F.-Q., Wu, Y., Wang, R.-H., Sun, Z., Fu, G., Mou, Y., Tao, W., Hu, X., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358676 · Cited by 85
Targeting Mitochondrial Calcium Handling and Reactive Oxygen Species in Heart Failure
Dietl, A., & Maack, C. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0347-7 · Cited by 89
Smyrnias, I., Zhang, X., Zhang, M., Murray, T. V., Brandes, R. P., Schröder, K., Brewer, A. C., & Shah, A. M. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.04208 · Cited by 83
Mitochondrial Dysfunction in Cardiovascular Diseases
Yang, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051917 · Cited by 91
Dong, W., Liu, Y., Zhou, L., Mao, Y., Wang, Y., Zhu, X., & Jiang, L. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.004 · Cited by 82
Zhang, L., Huang, S., Ma, X., Zhang, W., Wang, D., Jin, S., Zhang, Y., Li, Y., & Li, X. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.07.014 · Cited by 82
Lin, L., Liu, X., Xu, J., Weng, L., Ren, J. T., Ge, J., & Zou, Y. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12687 · Cited by 83
Hashemzaei, M., Heravi, R. E., Rezaee, R., Roohbakhsh, A., & Karimi, G. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.02.038 · Cited by 83
Autophagy in metabolic syndrome: breaking the wheel by targeting the renin–angiotensin system
Menikdiwela, K. R., Ramalingam, L., Rasha, F. A., Wang, S. F., Dufour, J. M., Kalupahana, N. S., Sunahara, K. K. S., Martins, J. O., & Moustaïd‐Moussa, N. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2275-9 · Cited by 82
Xu, H., Ranjit, R., Richardson, A. G., & Remmen, H. V. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12768 · Cited by 81
Kadoguchi, T., Kinugawa, S., Takada, S., Fukushima, A., Furihata, T., Homma, T., Masaki, Y., Mizushima, W., Nishikawa, M., Takahashi, M., et al. (2015) · Experimental Physiology · doi:10.1113/expphysiol.2014.084095 · Cited by 81
Oxidative Stress and Autophagy in Cardiovascular Homeostasis
Morales, C. R., Pedrozo, Z., Lavandero, S., & Hill, J. A. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5359 · Cited by 81
Choi, Y. S., de Mattos, A. B. M., Shao, D., Li, T., Nabben, M., Kim, M., Wang, W., Tian, R., & Kolwicz, S. C. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.09.001 · Cited by 78
Octavia, Y., Rocca, H. B., & Moens, A. L. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.482 · Cited by 75
Ayyappan, P., Vineetha, V. P., & Raghu, K. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096220 · Cited by 75
Mitochondrial Ca2+ Homeostasis: Emerging Roles and Clinical Significance in Cardiac Remodeling
Zhang, D., Wang, F., Li, P., & Gao, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063025 · Cited by 81
The role of autophagy in angiotensin II-induced pathological cardiac hypertrophy
Zhou, L., Ma, B., & Han, X. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0086 · Cited by 75
miR-106a promotes cardiac hypertrophy by targeting mitofusin 2
Guan, X., Wang, L., Liu, Z., Guo, X., Jiang, Y., Lu, Y., Peng, Y., Liu, T., Yang, B., Shan, H., et al. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.08.016 · Cited by 73
Cao, T., Fan, S., Zheng, D., Wang, G., Yu, Y. Q., Chen, R., Song, L., Fan, G., Zhang, Z., & Peng, T. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-019-0726-1 · Cited by 73
Daiber, A., Andreadou, I., Oelze, M. W., Davidson, S. M., & Hausenloy, D. J. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.026 · Cited by 75
Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity
Mehrabadi, M. E., Hemmati, R., Tashakor, A., Homaei, A. A., Yousefzadeh, M., Hemati, K., & Hosseinkhani, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111363 · Cited by 75
Dai, D., & Rabinovitch, P. S. (2011) · Autophagy · doi:10.4161/auto.7.8.15813 · Cited by 73
Self-citationAlterations in mitochondrial function in cardiac hypertrophy and heart failure
Osterholt, M., Nguyễn, T. D., Schwarzer, M., & Doenst, T. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9346-7 · Cited by 71
Mitochondria and Cardiac Hypertrophy.
Facundo, H. D. T. F., Brainard, R. E., Caldas, F. R. D. L., & Lucas, A. M. B. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-55330-6_11 · Cited by 70
McCommis, K. S., Douglas, D. L., Krenz, M., & Baines, C. P. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000355 · Cited by 71
Giusti, V. C. D., Caldiz, C. I., Ennis, I. L., Pérez, N. G., Cingolani, H. E., & Aiello, E. A. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00126 · Cited by 76
Tian, Z., Miyata, K., Kadomatsu, T., Horiguchi, H., Fukushima, H., Tohyama, S., Ujihara, Y., Okumura, T., Yamaguchi, S., Zhao, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms13016 · Cited by 72
D’Souza, A. D., Parish, I. A., Krause, D. S., Kaech, S. M., & Shadel, G. S. (2012) · Molecular Therapy · doi:10.1038/mt.2012.203 · Cited by 73
Huo, S., Shi, W., Ma, H., Yan, D., Luo, P., Guo, J., Li, C., Lin, J., Zhang, C., Li, S., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6699054 · Cited by 72
RetractedWei, K.-H., Lin, I.-T., Chowdhury, K., Lim, K. L., Liu, K., Ko, T., Chang, Y., Yang, K., & Lai, S.-L. (2023) · eLife · doi:10.7554/elife.84679 · Cited by 73
Chen, W., Chen, C.-H., Hsu, M., Chang, R.-W., Wang, C., & Lee, T. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116192 · Cited by 70
Impaired mitochondrial network excitability in failing guinea-pig cardiomyocytes
Goh, K. Y., Qu, J. T., Hong, H., Liu, T., Dell’Italia, L. J., Wu, Y., O'Rourke, B. P., & Zhou, L. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv230 · Cited by 70
Koju, N., Taleb, A., Zhou, J., Ge, L., Yang, J., Cao, X., Lei, H., & Ding, Q. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.128 · Cited by 72
GRK5 is a regulator of fibroblast activation and cardiac fibrosis
Eguchi, A., Coleman, R. C., Gresham, K. S., Gao, E., Ibetti, J., Chuprun, J. K., & Koch, W. J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012854118 · Cited by 68
Schwarzer, M., Osterholt, M., Lunkenbein, A., Schrepper, A., Amorim, P., & Doenst, T. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.274704 · Cited by 68
Mitochondrial Reprogramming Induced by CaMKIIδ Mediates Hypertrophy Decompensation
Westenbrink, B. D., Ling, H., Divakaruni, A. S., Gray, C. B. B., Zambon, A. C., Dalton, N. D., Peterson, K. L., Gu, Y., Matkovich, S. J., Murphy, A. N., et al. (2015) · Circulation Research · doi:10.1161/circresaha.116.304682 · Cited by 69
Self-citationValsartan Regulates Myocardial Autophagy and Mitochondrial Turnover in Experimental Hypertension
Zhang, X., Li, Z.-L., Crane, J. A., Jordan, K. L., Pawar, A. S., Textor, S. C., Lerman, A., & Lerman, L. O. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02151 · Cited by 69
Dries, E., Santiago, D. J., Gilbert, G., Lenaerts, I., Vandenberk, B., Nagaraju, C. K., Johnson, D. M., Holemans, P., Roderick, H. L., Macquaide, N., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy088 · Cited by 68
Ni, Y., Deng, J., Liu, X., Li, Q., Zhang, J., Bai, H., & Zhang, J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15904 · Cited by 66
Cooper, S. L., Boyle, E., Jefferson, S. R., Heslop, C., Mohan, P., Mohanraj, G. G. J., Sidow, H. A., Tan, R. C. P., Hill, S. J., & Woolard, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158255 · Cited by 70
Mitochondrial dysfunction in heart failure and its therapeutic implications
Liu, M., Lv, J., Pan, Z., Wang, D., Zhao, L., & Guo, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.945142 · Cited by 75
Hoshino, A., Okawa, Y., Ariyoshi, M., Kaimoto, S., Uchihashi, M., Fukai, K., Iwai‐Kanai, E., & Matoba, S. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.001062 · Cited by 68
New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseases
Lisa, F. D., Giorgio, M., Ferdinándy, P., & Schulz, R. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13478 · Cited by 66
Eirin, A., Ebrahimi, B., Kwon, S. H., Fiala, J. A., WILLIAMS, B. J., Woollard, J. R., He, Q., Gupta, R. C., Sabbah, H. N., Prakash, Y. S., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003118 · Cited by 67
Hydrogen (H2) Inhibits Isoproterenol-Induced Cardiac Hypertrophy via Antioxidative Pathways
Zhang, Y., Xu, J., Long, Z., Wang, C., Wang, L., Sun, P., Li, P., & Wang, T. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00392 · Cited by 67
Jain, A., Behera, M., Mahapatra, C., Sundaresan, N. R., & Chatterjee, K. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111416 · Cited by 66
Impact of the renin–angiotensin system on cardiac energy metabolism in heart failure
Mori, J., Zhang, L., Oudit, G. Y., & Lopaschuk, G. D. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.07.010 · Cited by 65
Mitochondrial accumulation under oxidative stress is due to defects in autophagy
Luo, C. Y., Li, Y., Wang, H., Feng, Z., Li, Y., Long, J., & Liu, J. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24356 · Cited by 68
Bertero, E., Nickel, A., Kohlhaas, M., Hohl, M., Sequeira, V., Brune, C., Schwemmlein, J., Abeßer, M., Schuh, K., Kutschka, I., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.053755 · Cited by 65
Intracellular Na+ and cardiac metabolism
Bay, J., Kohlhaas, M., & Maack, C. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.05.010 · Cited by 66
How cardiomyocytes sense pathophysiological stresses for cardiac remodeling
Haque, Z. K., & Wang, D. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2373-0 · Cited by 64
Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy
Yang, D., Liu, H., Liu, F.-Y., Guo, Z., An, P., Wang, M., Yang, Z., Fan, D., & Tang, Q. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.822969 · Cited by 64
Mitochondrial-Targeted Catalase
Dai, D., Chiao, Y. A., Martin, G. M., Marcinek, D. J., Basisty, N., Quarles, E. K., & Rabinovitch, P. S. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.015 · Cited by 65
Self-citationMitochondria, Myocardial Remodeling, and Cardiovascular Disease
Verdejo, H., del Campo, A., Troncoso, R., Gutiérrez, T., Toro, B., Quiroga, C., Pedrozo, Z., Muñoz, J. P., Garcı́a, L., Castro, P., et al. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0305-4 · Cited by 63
de Cavanagh, E. M. V., Inserra, F., & Ferder, L. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00459.2014 · Cited by 66
Vázquez‐Medina, J. P., Popovich, I. Y., Thorwald, M. A., Viscarra, J. A., Rodríguez, R., Soñanez‐Organis, J. G., Lam, L., Peti‐Peterdi, J., Nakano, D., Nishiyama, A., et al. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00101.2013 · Cited by 63
Calkins, M. J., & Reddy, P. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.04.006 · Cited by 65
Toledo, C., Andrade, D. C., Díaz, H. S., Inestrosa, N. C., & Rio, R. D. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01655-0 · Cited by 58
Zhang, X., Zheng, C., Gao, Z., Wang, L., Chen, C., Zheng, Y., & Meng, Y. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17007 · Cited by 61
Regulation of miRNAs by Natural Antioxidants in Cardiovascular Diseases: Focus on SIRT1 and eNOS
Lee, Y., & Im, E. (2021) · Antioxidants · doi:10.3390/antiox10030377 · Cited by 59
Wu, K., Li, B., Lin, Q., Xu, W., Zuo, W., Li, J., Liu, N., Tu, T., Zhang, B., Xiao, Y., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119299 · Cited by 59
Redox signaling in heart failure and therapeutic implications
Weissman, D., & Maack, C. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.013 · Cited by 60
Hsieh, E. J., Shulman, N., Dai, D., Vincow, E. S., Karunadharma, P. P., Pallanck, L. J., Rabinovitch, P. S., & MacCoss, M. J. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o112.017699 · Cited by 56
Self-citationQin, F., Siwik, D. A., Pimentel, D. R., Morgan, R. J., Biolo, A., Tu, V. H., Kang, Y. J., Cohen, R. A., & Colucci, W. S. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00084.2014 · Cited by 57
Self-citationMcLachlan, J., Beattie, E. C., Murphy, M. P., Koh-Tan, H. H. C., Olson, E. D., Beattie, W., Dominiczak, A. F., Nicklin, S. A., & Graham, D. (2013) · Journal of Hypertension · doi:10.1097/hjh.0000000000000054 · Cited by 56
Kramer, P. A., Duan, J., Qian, W.-J., & Marcinek, D. J. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00347 · Cited by 54
Involvement of Oxidative Stress in the Development of Subcellular Defects and Heart Disease
Dhalla, N. S., Elimban, V., Barteková, M., & Adameová, A. (2022) · Biomedicines · doi:10.3390/biomedicines10020393 · Cited by 57
Integration of superoxide formation and cristae morphology for mitochondrial redox signaling
Plecitá‐Hlavatá, L., & Ježek, P. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.09.010 · Cited by 57
Yan, S., Zhao, N., Geng, Z., Shen, J., Liu, F., Yan, D., Zhou, J., Nie, C., Huang, C., & Fang, Z. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.12.001 · Cited by 55
Myocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact
Lunde, I. G., Rypdal, K. B., Linthout, S. V., Díez, J., & González, A. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.08.008 · Cited by 61
Mechano-energetic uncoupling in heart failure
Aksentijević, D., Sedej, S., Fauconnier, J., Paillard, M., Abdellatif, M., Streckfuß‐Bömeke, K., Ventura‐Clapier, R., van der Velden, J., de Boer, R. A., Bertero, E., et al. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01167-6 · Cited by 55
Wang, Y., Li, C., Cheng, K., Zhang, R., Narsinh, K. H., Li, S., Li, X., Qin, X., Zhang, R., Li, C., et al. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5683 · Cited by 54
Dubey, D., Chopra, D., Singh, J., Srivastav, A. K., Kumari, S., Verma, A., & Ray, R. S. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.07.056 · Cited by 53
Zeng, J., Zhao, J., Dong, B., Cai, X., Jiang, J., Xue, R., Yao, F., Dong, Y., & Liu, C. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.01.002 · Cited by 53
Metadata
- Authors
- Dai, D.-F., Johnson, S. C., Villarin, J. J., Chin, M. T., Nieves-Cintrón, M., Chen, T., Marcinek, D. J., Dorn, G. W., Kang, Y. J., Prolla, T. A., Santana, L. F., & Rabinovitch, P. S.
- Affiliations
- University of Louisville (US)
- From the Departments of Pathology (D.-F.D., S.C.J., T.C., P.S.R.), Radiology (J.J.V., D.J.M.), Cardiovascular Medicine (M.T.C.), Physiology and Biophysics (M.N.-C., L.F.S.), University of Washington, Seattle; Department of Internal Medicine (G.W.D.), Washington University School of Medicine, St Louis, MO; Departments of Medicine and Pharmacology and Toxicology (Y.J.K.), University of Louisville School of Medicine, KY; and Department of Genetics and Medical Genetics (T.A.P.), University of...
- ORCID
- Venue
- Circulation Research
- Published
- 2011-04
- Volume
- 108
- Issue
- 7
- Pages
- 837-846
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC3785241
- OpenAlex
- W2117205119
- Cited by
- 527
- References
- 35
- Citations by year
- 2026: 14 · 2025: 35 · 2024: 30 · 2023: 32 · 2022: 28 · 2021: 42 · 2020: 46 · 2019: 34 · 2018: 31 · 2017: 29 · 2016: 44 · 2015: 34 · 2014: 37 · 2013: 36 · 2012: 41
- FWCI
- 16.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (AG001751, AG013280)
- National Institute on Aging (AG-028455, AG001751, P01AG001751, AG013280, AG035844, RC1AG035844, R01AG028455, P30AG013280)
- National Heart, Lung, and Blood Institute (R01HL101186, HL-101186, R01HL063760, HL063760, R01HL059888)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- mitochondrial oxidative stress, reactive oxygen species, angiotensin II, cardiac hypertrophy, heart failure, catalase, mitochondrial DNA damage, mitochondrial DNA deletions, autophagy, mitochondrial biogenesis, hypertensive cardiomyopathy, myocardial fibrosis, zidovudine, mitochondria-targeted antioxidants
- MeSH terms
- Angiotensin II, Animals, Catalase, DNA Damage, DNA, Mitochondrial, Gene Expression Regulation, Cardiomegaly, Heart Failure, Mice, Transgenic, Mitochondria, Heart, Zidovudine, Reactive Oxygen Species, Oxidative Stress, Reverse Transcriptase Inhibitors, Models, Animal, Myocytes, Cardiac, GTP-Binding Protein alpha Subunits, Gq-G11, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review